Search results
Can semaglutide drugs lower alcohol use disorder incidence?
Medical News Today· 1 day agoA new study from Case Western Reserve University School of Medicine reveals that popular diabetes ...
Saxenda vs. Ozempic: How these drugs compare
Medical News Today· 3 days agoSaxenda (liraglutide) and Ozempic (semaglutide) are brand-name solutions for subcutaneous injection. Saxenda is approved for weight management. Doctors...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 2 days agoBut how did the category evolve, and what are the opportunities and risks for investors? The...
Zepbound Effective for Weight Loss for People with Multiple Conditions
Healthline· 5 days agoExperts say the results point to the notion that the drug should continue to be used as directed,...
High price of popular diabetes drugs deprives low-income people of effective treatment
New Hampshire Union Leader· 5 days agoFor the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes,...
A Complete Guide to Type 1 Diabetes Medications
Verywell Health via Yahoo News· 2 days agoInsulin is the most common medication used to treat type 1 diabetes. Learn more about insulin and other medications often prescribed to help manage this...
Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
Digital Journal· 22 hours agoSecond study arm dosing is now complete. KELOWNA, BC / ACCESSWIRE / June 5, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in < ...
Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement | Law.com
Law.com· 2 days agoThe pharmaceutical company filed nine lawsuits accusing the defendants of misappropriating its marks...
General Mills faces pressure to remove plastic chemicals from food
CBS News via Yahoo News· 7 days ago"There are no regulatory requirements at this point," said Ronholm, who also urged federal...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool via AOL· 4 days agoToday, GLP-1 agonists are primarily used to treat diabetes and obesity. However, research suggests...